Dr. James Carter | Molecular Biology | Best Researcher Award
Assistant Professor at Georgia Southern University, United States
Dr. James R. Carter is an accomplished scientist and educator with a robust academic and professional background in biochemistry and molecular biology. Currently serving as an Assistant Professor in the Department of Chemistry & Biochemistry at Georgia Southern University, Dr. Carter has made significant contributions to the fields of viral pathogenesis, antiviral development, and nanoparticle-based drug delivery systems. His career has spanned academia and industry, where he has spearheaded groundbreaking research and innovation. Dr. Carter has successfully mentored numerous graduate and undergraduate students, contributing to their academic and professional growth. His dedication to teaching, research, and service underscores his commitment to advancing scientific knowledge and fostering the next generation of scientists.
Professional Profile
Education
Dr. Carter earned his PhD in Molecular and Cellular Biochemistry from the University of Kentucky in 2007. His dissertation focused on the fusion proteins of Hendra virus, an emerging paramyxovirus, contributing valuable insights into viral protein functionality. Prior to this, he completed a Bachelor of Science in Biochemistry at Plattsburgh State University in 2000, where he developed foundational skills in biochemistry, microbiology, and genetics. This strong educational foundation has been instrumental in his ability to conduct and lead advanced research in biochemistry and virology.
Professional Experience
Dr. Carter’s professional journey includes diverse roles in academia and industry. Since 2019, he has served as an Assistant Professor at Georgia Southern University, leading research on flavivirus pathogenesis, antiviral development, and nanoparticle-based drug delivery systems. Previously, he worked as a Senior Scientist at ViroCure USA, where he explored oncolytic viruses for cancer therapeutics. At Indiana University School of Medicine and the University of Notre Dame, he contributed to groundbreaking research on mosquito-borne viruses and matrix protein functionality in filoviruses. His career reflects a commitment to impactful, interdisciplinary research.
Research Interests
Dr. Carter’s research interests lie at the intersection of viral pathogenesis, antiviral therapies, and advanced drug delivery systems. His work focuses on developing innovative approaches to detect, target, and treat mosquito-borne viruses and emerging pathogens. He is particularly interested in using nanoparticles to enhance drug delivery, offering targeted and efficient solutions for combating viral infections. His research combines molecular biology, biochemistry, and nanotechnology to address pressing public health challenges.
Research Skills
Dr. Carter possesses a wide array of research skills, including advanced molecular biology techniques, nanoparticle synthesis, and viral detection methodologies. He has demonstrated expertise in site-directed mutagenesis, protein folding analysis, and drug delivery system design. Additionally, his experience in grant writing, patent preparation, and regulatory compliance showcases his ability to translate scientific discoveries into practical applications. His skill set is further complemented by his ability to mentor and lead diverse research teams effectively.
Awards and Honors
Dr. Carter has received numerous accolades for his contributions to science and education. These include the ACS Sci-Mix Abstract Selection at the ACS National Meeting, travel awards from the American Society for Virology, and recognition for his teaching and mentoring excellence. His patented innovations in DNAzyme-nanoparticle conjugates further highlight his contributions to cutting-edge research. These achievements underscore his standing as a leader in his field.
Conclusion
Dr. James R. Carter’s extensive academic and professional achievements make him a distinguished candidate for the Best Researcher Award. His innovative research, commitment to education, and dedication to advancing science have had a lasting impact on his field and beyond. While there is room for further accomplishments, particularly in grant acquisition and publication impact, his current contributions firmly establish him as a leading figure in biochemistry and molecular biology.
Publication Top Notes
- Application of mPEG-PCL-mPEG Micelles for Anti-Zika Ribavirin Delivery
- Authors: Blahove, M.R.; Saviskas, J.A.; Rodriguez, J.; Culmer, J.A.; Carter, J.R.
- Year: 2024
- Flavivirus persistence in wildlife populations
- Authors: Blahove, M.R.; Carter, J.R.
- Year: 2021
- Citations: 8
- Suppression of the arboviruses dengue and chikungunya using a dual-acting group-I intron coupled with conditional expression of the Bax C-terminal domain
- Authors: Carter, J.R.; Taylor, S.; Fraser, T.S.; Dawson, J.L.; Fraser, M.J.
- Year: 2015
- Citations: 14
- Trans-splicing group I intron targeting hepatitis C virus IRES mediates cell death upon viral infection in Huh7.5 cells
- Authors: Nawtaisong, P.; Fraser, M.E.; Carter, J.R.; Fraser, M.J.
- Year: 2015
- Citations: 6
- Effective suppression of Dengue virus using a novel group-I intron that induces apoptotic cell death upon infection through conditional expression of the Bax C-terminal domain
- Authors: Carter, J.R.; Keith, J.H.; Fraser, T.S.; Higgs, S.; Fraser, M.J.
- Year: 2014
- Citations: 20
- Design and analysis of hammerhead ribozyme activity against an artificial gene target
- Authors: Carter, J.R.; Nawtaisong, P.; Balaraman, V.; Fraser Jr., M.J.
- Year: 2014
- A novel dengue virus detection method that couples DNAzyme and gold nanoparticle approaches
- Authors: Carter, J.R.; Balaraman, V.; Kucharski, C.A.; Fraser, T.S.; Fraser, M.J.
- Year: 2013
- Citations: 33
- Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns
- Authors: Carter, J.R.; Keith, J.H.; Barde, P.V.; Fraser, T.S.; Fraser Jr, M.J.
- Year: 2010
- Citations: 29
- Examining the relative activity of several dicistrovirus intergenic internal ribosome entry site elements in uninfected insect and mammalian cell lines
- Authors: Carter, J.R.; Fraser, T.S.; Fraser Jr., M.J.
- Year: 2008
- Citations: 14
